Adult patients in whom testing for GHD can be considered.
|(i) Those with structural lesions of hypothalamic-pituitary region for example, pituitary adenoma, craniopharyngioma|
|(ii) Following surgery to the hypothalamic-pituitary region|
|(iii) Those with biochemical evidence of hypopituitarism for example, central hypothyroidism|
|(iv) Those with genetic conditions associated with hypopituitarism for example, PIT-1, PROP-1 mutations|
|(v) Following cranial irradiation|
|(vi) Following moderate to severe traumatic brain injury and possibly aneurysmal subarachnoid haemorrhage|